Effect of octreotide acetate on thyrotropin-secreting adenoma: Report of two cases and review of the literature

Endocrine Regulations

Volumn 33, Issue 4, 1999, Pages 169-174

  Yöenem, Arif ^a,b   Cakyr, B ^a   Azal, Oe ^a   Corakcy, A ^a   Kutlu, M ^a   Oezata, M ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Case reports; Minireview; Octreotide treatment; TSH secreting adenoma

Indexed keywords

OCTREOTIDE; THYROID HORMONE; THYROTROPIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; HORMONE BLOOD LEVEL; HORMONE INHIBITION; HUMAN; MALE; THYROID ADENOMA; THYROTROPIN RELEASE; TUMOR VOLUME;

ADENOMA; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OCTREOTIDE; PITUITARY NEOPLASMS; SODIUM PERTECHNETATE TC 99M; THYROTROPIN; ULTRASONOGRAPHY;

EID: 0342680214     PISSN: 00137200     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. GIROD C, TROUILLAS J, CLAUSTRAT B: The human thyrotropic adenoma: pathologic diagnosis in five cases and critical review of the literature. Semin Diagn Pathol 3, 58-68, 1986
2. MAGNER JA: TSM-mediated hyperthyroidism. Endocrinologist 3, 289-296, 1993
3. REFETOFF S, WEISS RE, USALA JJ: The syndrome of resistance to thyroid hormone. Endocrine Rev 14, 348-399, 1993
4. PERSANI I, PRESIZIATI D, MATTHEWS CH et al.: Serum levels of carboxyterminal cross-linked telopeptide of type I collagen in the differential diagnosis of the syndromes of inappropriate secretion of TSH. Clin Endocrinol (Oxf) 47, 207-214, 1997
5. LEE EJ, KIM KR, LIM SK et al.: Reduction in tumor size of a thyrotropin-secreting pituitary adenoma treated with octreotide acetate (somatostatin analog). Eur J Endocrinol 131, 109-112. 1994.
6. Kamio M. Thyrotropin secreting adenoma. Nippon Rinsho 1993;51:2701-2705 (Abstr).
7. BECKERS A, ABS R, MAHLER C et al.: Thyrotropin secreting adenomas: report of seven cases. J Clin Endocrinol Metab 72, 477-483, 1991
8. KORN EA, GAICH G, BRINES M, CARPENTER TO: Thyrotropin-secreting adenoma in an adolescent girl without increased serum thyrotropin alpha. Horm Metab Res 1994;42, 120-123, 1994
9. SMALLRIDGE RC: Thyrotropin secreting tumors. In: Endocrine tumors (Mazzaferri EL and Samaan NA, eds), pp. 136-151, Blackwell, Boston 1994
10. MCCUTHEAN IE, WEINTRAUB BD, OLDFIELD EH: Surgical treatment of thyrotropin secreting pituitary adenomas. J Neurosurg 73, 674-683, 1990
11. GANCEL A, VUILLERMET P, LEGRAND A et al.: Effects of a slow releasing formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas. Clin Endocrinol (Oxf) 40, 421-428, 1994
12. MAYINGER B, AXELOS D, PAVEL M, HAHN EG, HENSEN J. Monosymptomatishe Hyperthyreose und TSH-produzierendes Adenom: Erfolgreiche Therapie mit Octreotid. Dtsch Med Wschr 124, 73-78, 1999
13. SY RA, BERNSTEIN R, CHYNN KY, KOURIDES TA: Reduction in size of a thyrotropin-and gonadotropin secreting pituitary adenoma treated with octreotide acetate (somatostatin analog). J Clin Endocrinol Metab 74, 690-694, 1992